Effect of Long-Acting Stimulants on Growth
The effect of OROS methylphenidate (OROS MPH, Concerta) [34-43 mg daily; 1.1-1.2 mg/kg/day] on the height and weight of 178 children, ages 6 to 13 years, treated for at least 21 months for attention-deficit/hyperactivity disorder (ADHD) was evaluated at the Massachusetts General Hospital, Boston.
Main Author: | J Gordon Millichap |
---|---|
Format: | Article |
Language: | English |
Published: |
Pediatric Neurology Briefs Publishers
2006-05-01
|
Series: | Pediatric Neurology Briefs |
Subjects: | |
Online Access: | https://www.pediatricneurologybriefs.com/articles/1154 |
Similar Items
-
Effects of OROS-MPH Versus Dl-Amphetamine-XR on Driving Performance of ADHD Adolescents
by: J Gordon Millichap
Published: (2006-10-01) -
Adverse Effects of Medications for ADHD: Priapism with Medication for ADHD
by: J Gordon Millichap, et al.
Published: (2014-08-01) -
Risk of Tics with Psychostimulants for ADHD
by: J. Gordon Millichap
Published: (2016-01-01) -
Brain Growth in Children at Risk for Huntington Disease
by: J Gordon Millichap
Published: (2012-10-01) -
Amphetamine-Associated Seizures
by: J Gordon Millichap
Published: (2011-04-01)